Trendlines Scores a Hat Trick at Israel’s Chief Scientist Awards

  • slider
  • slider
  • slider
  • slider
  • slider
  • slider
  • slider
  • slider
  • slider
  • slider
preview
up

Trendlines Medical and two portfolio companies of The Trendlines Group keep Trendlines on its award-winning path.

Tel Aviv, Israel, June 11, 2014 – Trendlines Medical received the Best Incubator award and two Trendlines portfolio companies received Best Start-Up of the Year — Advanced Mem-Tech (Trendlines Agtech) and MitrAssist  (Trendlines Medical) — from Israel’s Office of the Chief Scientist of the Ministry of Economy (OCS).  Browse our photo gallery from the event (Facebook and Flickr).

This is the third year running that Trendlines’ companies have received OCS awards. The recognition verifies the hard work and diligence of the companies and of Trendlines’ investment methodology and portfolio company support business model. (Portfolio companies Liola and MediValve were among the 17 Best Start-up nominees. See the OCS video about Liola and the video about MediValve.)

         

Trendlines Medical has twice received the prestigious Best Incubator award; the first time in 2010. Eran Feldhay, CEO of Trendlines Medical, says: “This honor is a testimony to our business processes and continued commitment to partnering with entrepreneurs to develop medical device technologies that improve patient outcomes and reduce health care costs.”

Advanced Mem-Tech develops innovative filtration membranes that separate solids from water during the treatment and purification of wastewater and clean water. Last year, the company’s founders were awarded the prize for Innovative Applied Engineering Research by the Technion-Israel Institute of Technology. Earlier this year, the company completed a $5 million capital raise. Nitza Kardish, CEO of Trendlines Agtech: “We are extremely proud of what Advanced Mem-Tech has achieved. This award reinforces our commitment to establishing companies that are focused on ‘improving the human condition’ while increasing production and enhancing sustainability.”

The minimally invasive implant from MitrAssist treats Mitral Regurgitation (MR), a condition that prevents the heart’s mitral valve from closing properly. Working in unison with the heart’s own valve, the proprietary implant uses a “valve-in-valve” approach to create a safe, cost-effective treatment solution for all MR patients. MitrAssist completed a $1 million raise in 2013.

Todd Dollinger, Chairman and CEO of Trendlines: “We are very proud that the OCS has again recognized Trendlines Medical and our portfolio companies — one from each of our incubators — and we greatly appreciate the outstanding work of our staff in helping our companies reach these excellent  achievements.”

“This event was dominated by Trendlines, which won three of the four titles awarded.” – Gali Weinreb, Globes,  June 11, 2014

From Globes

“At the annual incubator program event, which took place yesterday, the outstanding incubators and companies were named. Trendlines Medical in Misgav was chosen as the outstanding tech incubator for 2013. … The Chief Scientist’s Office said that the Misgav incubator was chosen due to the quality of its ventures, the close support they received and continue to receive from the group and the incubator staff, and the success of the veteran companies in raising funds from private investors and establishing strategic partnerships.

“Three companies were named as outstanding incubator companies: Advanced MemTech, a Trendlines Agtech graduate that is developing membranes with improved performance for water treatment; MitrAssist, a Trendlines Medical graduate that is developing a mitral valve implant to treat heart patients ….

“This event was dominated by Trendlines, which won three of the four titles awarded.”

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+